This is why medical supervision matters when starting GLP-1 therapy
During the 48-week treatment, IP-10 declined significantly from baseline to 48 weeks (0W, 12W, 24w, 48w median: 671.3 vs 431.3 vs 287.3 vs 269.5 pg/mL, p 1000 pg/mL was an independent predictor of complete virological response at 48 weeks (OR=5.26, 95% CI:1.27-21.71, p =0.022)
Injection with a separately identifiable E/M: Bill both
To understand the significance of GLP-1 drugs, it is essential to appreciate the background of the incretin effect and the early quest for gut-derived diabetes treatments
Device-level biometrics can speed secure entry, though they should never replace robust passwords and two-factor authentication when available
We plan for this from the beginning rather than treating it as something to figure out at the end